Nextage Therapeutics Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY	FY
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	-	0.4	-	3.26	2.03
Short-Term Investments	0.25	0.08	-	0.1	0.04
Cash & Short-Term Investments	0.25	0.48	-	3.36	2.07
Cash Growth	-47.18%	-	-	62.49%	-
Accounts Receivable	0.05	0.25	-	0.03	-
Other Receivables	0.02	0.14	-	0.66	0.44
Receivables	0.06	0.4	-	0.68	0.44
Prepaid Expenses	-	-	-	0.08	0.01
Other Current Assets	0	0.01	-	0.03	-
Total Current Assets	0.32	0.89	-	4.16	2.51
Property, Plant & Equipment	0.04	0.21	-	0.12	0.24
Other Intangible Assets	-	-	-	-	1.32
Total Assets	0.35	1.1	-	4.27	4.07
Accounts Payable	0.24	0.12	-	0.45	0.21
Accrued Expenses	5.4	3.29	-	1.9	1.03
Short-Term Debt	0.16	0.23	-	-	-
Current Portion of Long-Term Debt	-	-	-	0.23	0.26
Current Portion of Leases	0.05	0.08	-	-	-
Total Current Liabilities	5.85	3.73	-	2.58	1.5
Long-Term Debt	-	-	-	1.12	0.58
Long-Term Leases	-	0.07	-	-	-
Other Long-Term Liabilities	0.04	0.04	-	0.07	0.54
Total Liabilities	5.89	3.83	-	3.76	2.62
Common Stock	-	60.54	-	52.29	50.76
Additional Paid-In Capital	63.15	1.43	-	4.79	2.71
Retained Earnings	-42.54	-39.26	-	-29.79	-22.06
Comprehensive Income & Other	-26.13	-25.61	-	-27.54	-29.96
Total Common Equity	-5.52	-2.9	-	-0.25	1.45
Minority Interest	-0.02	0.16	-	0.77	-
Shareholders' Equity	-5.54	-2.74	-	0.52	1.45
Total Liabilities & Equity	0.35	1.1	-	4.27	4.07
Total Debt	0.21	0.38	-	1.35	0.84
Net Cash (Debt)	0.04	0.1	-	2.02	1.23
Net Cash Growth	-57.43%	-	-	64.09%	-
Net Cash Per Share	0.00	0.00	-	0.08	0.11
Filing Date Shares Outstanding	33.7	29.18	27.85	26.14	11.43
Total Common Shares Outstanding	33.7	29.18	27.85	26.14	11.43
Working Capital	-5.54	-2.84	-	1.58	1.01
Book Value Per Share	-0.16	-0.10	-	-0.01	0.13
Tangible Book Value	-5.52	-2.9	-	-0.25	0.13
Tangible Book Value Per Share	-0.16	-0.10	-	-0.01	0.01
Machinery	0.19	0.19	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.